osteoarthritis

osteoarthritis
Name	Osteoarthritis
Field	Rheumatology, Orthopedics
Symptoms	Joint pain, stiffness, decreased function
Onset	Variable
Duration	Chronic
Causes	Multifactorial
Risks	Age, obesity, joint injury
Differential	Rheumatoid arthritis, gout

osteoarthritis Osteoarthritis is a chronic joint disorder characterized by degeneration of articular cartilage and changes in subchondral bone, producing pain and functional limitation. It commonly affects knees, hips, hands, and spine and contributes substantially to disability worldwide. Treatment focuses on symptom control, maintaining mobility, and reducing disability through nonpharmacologic, pharmacologic, and surgical interventions.

Signs and symptoms

Patients typically present with joint pain, stiffness after inactivity, crepitus, and reduced range of motion. Involvement of the knee, hip, hand interphalangeal joints, and cervical or lumbar spine produces patterns recognizable to clinicians from institutions such as Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, Mount Sinai Hospital, and Massachusetts General Hospital. Morning stiffness usually lasts under 30 minutes; activity-related pain and joint instability may lead to disability observed in registries like the Framingham Heart Study, Nurses' Health Study, and data collections at World Health Organization surveillance programs.

Causes and risk factors

Etiology is multifactorial: cumulative mechanical stress, prior joint trauma, congenital anomalies (e.g., developmental dysplasia of the hip), metabolic factors, and genetic predisposition. Age is the strongest risk factor, with increasing prevalence documented in cohorts from United Kingdom Biobank, National Health and Nutrition Examination Survey, Rotterdam Study, Iowa Women's Health Study, and British Regional Heart Study. Obesity elevates knee osteoarthritis risk via biomechanical load and adipokine-mediated inflammation; large-scale studies from Harvard University, Stanford University, University of Oxford, Imperial College London, and University of California, San Francisco have quantified these associations. Occupational joint loading seen in miners, construction workers, and professional athletes from organizations like International Olympic Committee and Fédération Internationale de Football Association correlates with higher incidence. Metabolic conditions such as diabetes and hemochromatosis, and systemic disorders like acromegaly, increase risk; familial clustering implicates loci identified in genome-wide association studies by consortia including the Wellcome Trust and European Molecular Biology Laboratory.

Pathophysiology

Pathologic processes include cartilage fibrillation, chondrocyte apoptosis, extracellular matrix degradation by matrix metalloproteinases and aggrecanases, subchondral bone sclerosis, osteophyte formation, and synovial inflammation. Mechanistic research from laboratories at National Institutes of Health, Karolinska Institutet, Max Planck Society, University of Cambridge, and Cold Spring Harbor Laboratory has elucidated roles for Wnt signaling, transforming growth factor beta, interleukin-1, tumor necrosis factor, and toll-like receptor pathways. Imaging correlates from Magnetic Resonance Imaging studies at Mayo Clinic and histopathologic analysis from surgical series at Cleveland Clinic and Johns Hopkins Hospital link structural changes to clinical outcomes measured in trials sponsored by agencies such as the National Institute for Health and Care Research and the U.S. Food and Drug Administration.

Diagnosis

Diagnosis is clinical, supported by radiography showing joint space narrowing, osteophytes, subchondral cysts, and sclerosis; plain films are interpreted using criteria developed in studies at Boston University, University of California, Los Angeles, and McMaster University. MRI, ultrasound, and CT provide additional detail and are used in research at centers like University College London and University of Toronto. Laboratory tests exclude inflammatory or crystalline arthropathies; synovial fluid analysis may be performed in collaboration with pathology departments at Mayo Clinic and Cleveland Clinic. Classification criteria used in epidemiologic studies derive from efforts by American College of Rheumatology and international working groups coordinated by the European League Against Rheumatism.

Management and treatment

Management combines self-management, physical therapy, weight loss, pharmacologic analgesia, intra-articular injections, and surgery. Guidelines from organizations including the American College of Rheumatology, National Institute for Health and Care Excellence, Arthritis Foundation, Canadian Rheumatology Association, and World Health Organization recommend exercise programs delivered by physiotherapists trained at institutions such as Karolinska Institutet and University of Sydney. Pharmacologic options include acetaminophen, NSAIDs, topical agents, and duloxetine per trials conducted at Harvard Medical School, Johns Hopkins University, and University of Pennsylvania. Intra-articular corticosteroids and hyaluronic acid are used variably; evidence syntheses by Cochrane and guideline bodies inform their roles. Surgical options—arthroscopy, osteotomy, and total joint arthroplasty—are performed in high-volume centers like Hospital for Special Surgery, Rush University Medical Center, Mayo Clinic, and Imperial College Healthcare NHS Trust. Rehabilitation programs post-arthroplasty are standardized in registries such as the National Joint Registry and research networks like the Orthopaedic Research Society.

Epidemiology

Global prevalence rises with population aging and obesity trends documented by United Nations demographic data and the World Health Organization. Large population studies, including the Global Burden of Disease collaboration and cohorts like the Framingham Heart Study, show osteoarthritis as a leading cause of years lived with disability. Incidence and severity vary by sex, with higher rates in women after middle age noted in analyses from European Prospective Investigation into Cancer and Nutrition, Women's Health Initiative, and national health surveys in United States, United Kingdom, Australia, and Sweden.

Prevention and prognosis

Primary prevention targets weight management, injury prevention in sports overseen by Fédération Internationale de Football Association and International Olympic Committee, ergonomic interventions in workplaces regulated by agencies like Occupational Safety and Health Administration, and public health measures advocated by the World Health Organization. Secondary prevention emphasizes early rehabilitation after joint injury, joint-preserving surgery at tertiary centers, and risk-factor modification in primary care settings such as NHS England and Kaiser Permanente. Prognosis varies: many individuals maintain function with conservative care, while progressive disease may require joint replacement, with outcomes tracked in registries like the American Joint Replacement Registry and the National Joint Registry.

Category:Musculoskeletal diseases